Cargando…

Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning

The bile acid activated transcription factor farnesoid X receptor (FXR) has revealed therapeutic potential as a molecular drug target for the treatment of hepatic and metabolic disorders. Despite strong efforts in FXR ligand development, the structural diversity among the known FXR modulators is lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Merk, Daniel, Grisoni, Francesca, Schaller, Kay, Friedrich, Lukas, Schneider, Gisbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317935/
https://www.ncbi.nlm.nih.gov/pubmed/30622878
http://dx.doi.org/10.1002/open.201800156
_version_ 1783384801356546048
author Merk, Daniel
Grisoni, Francesca
Schaller, Kay
Friedrich, Lukas
Schneider, Gisbert
author_facet Merk, Daniel
Grisoni, Francesca
Schaller, Kay
Friedrich, Lukas
Schneider, Gisbert
author_sort Merk, Daniel
collection PubMed
description The bile acid activated transcription factor farnesoid X receptor (FXR) has revealed therapeutic potential as a molecular drug target for the treatment of hepatic and metabolic disorders. Despite strong efforts in FXR ligand development, the structural diversity among the known FXR modulators is limited. Only four molecular frameworks account for more than 50 % of the FXR modulators annotated in ChEMBL. Here, we leverage machine learning methods to expand the chemical space of FXR‐targeting small molecules by employing an ensemble of three complementary machine learning approaches. A counter‐propagation artificial neural network, a k‐nearest neighbor learner, and a three‐dimensional pharmacophore descriptor were combined to retrieve novel FXR ligands from a collection of more than 3 million compounds. The ensemble machine learning model identified six new FXR modulators among ten top‐ranked candidates. These active hits comprise both FXR activators and antagonists with micromolar potencies. With four novel FXR ligand scaffolds, these computationally identified bioactive compounds appreciably expand the chemical space of known FXR modulators and may serve as starting points for hit‐to‐lead expansion.
format Online
Article
Text
id pubmed-6317935
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63179352019-01-08 Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning Merk, Daniel Grisoni, Francesca Schaller, Kay Friedrich, Lukas Schneider, Gisbert ChemistryOpen Full Papers The bile acid activated transcription factor farnesoid X receptor (FXR) has revealed therapeutic potential as a molecular drug target for the treatment of hepatic and metabolic disorders. Despite strong efforts in FXR ligand development, the structural diversity among the known FXR modulators is limited. Only four molecular frameworks account for more than 50 % of the FXR modulators annotated in ChEMBL. Here, we leverage machine learning methods to expand the chemical space of FXR‐targeting small molecules by employing an ensemble of three complementary machine learning approaches. A counter‐propagation artificial neural network, a k‐nearest neighbor learner, and a three‐dimensional pharmacophore descriptor were combined to retrieve novel FXR ligands from a collection of more than 3 million compounds. The ensemble machine learning model identified six new FXR modulators among ten top‐ranked candidates. These active hits comprise both FXR activators and antagonists with micromolar potencies. With four novel FXR ligand scaffolds, these computationally identified bioactive compounds appreciably expand the chemical space of known FXR modulators and may serve as starting points for hit‐to‐lead expansion. John Wiley and Sons Inc. 2018-10-02 /pmc/articles/PMC6317935/ /pubmed/30622878 http://dx.doi.org/10.1002/open.201800156 Text en © 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Full Papers
Merk, Daniel
Grisoni, Francesca
Schaller, Kay
Friedrich, Lukas
Schneider, Gisbert
Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning
title Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning
title_full Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning
title_fullStr Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning
title_full_unstemmed Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning
title_short Discovery of Novel Molecular Frameworks of Farnesoid X Receptor Modulators by Ensemble Machine Learning
title_sort discovery of novel molecular frameworks of farnesoid x receptor modulators by ensemble machine learning
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317935/
https://www.ncbi.nlm.nih.gov/pubmed/30622878
http://dx.doi.org/10.1002/open.201800156
work_keys_str_mv AT merkdaniel discoveryofnovelmolecularframeworksoffarnesoidxreceptormodulatorsbyensemblemachinelearning
AT grisonifrancesca discoveryofnovelmolecularframeworksoffarnesoidxreceptormodulatorsbyensemblemachinelearning
AT schallerkay discoveryofnovelmolecularframeworksoffarnesoidxreceptormodulatorsbyensemblemachinelearning
AT friedrichlukas discoveryofnovelmolecularframeworksoffarnesoidxreceptormodulatorsbyensemblemachinelearning
AT schneidergisbert discoveryofnovelmolecularframeworksoffarnesoidxreceptormodulatorsbyensemblemachinelearning